SERPINA1 and systemic lupus erythematosus: These clinical stages of SLE severity were previously found to be associated with the different phenotypes of alpha-1 antitrypsin [37], suggesting that the validation of alpha-1 antitrypsin level in SLE’ serum should further consider the clinical association and also the IL-6 level of the patients.